Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$712M |
| 2 |
PepsiCo
PEP
|
+$669M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$635M |
| 4 |
Walmart Inc
WMT
|
+$544M |
| 5 |
Palantir
PLTR
|
+$538M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.34B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.65B |
| 3 |
Tesla
TSLA
|
+$1.45B |
| 4 |
Invesco QQQ Trust
QQQ
|
+$1.01B |
| 5 |
Apple
AAPL
|
+$833M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.48% |
| 2 | Financials | 7.27% |
| 3 | Consumer Discretionary | 6.82% |
| 4 | Communication Services | 5.06% |
| 5 | Healthcare | 4.31% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
351
Baker Hughes
BKR
$58.3B
| $162M | 0.04% |
3,333,953
-1,184,481
| -26% | -$52.3M |
|
352
Ameriprise Financial
AMP
$47.8B
| $162M | 0.04% |
329,419
-56,524
| -15% | -$29M |
|
353
Kimberly-Clark
KMB
$37.6B
| $161M | 0.03% |
1,293,919
+365,586
| +39% | +$47.3M |
|
354
CMS Energy
CMS
$23B
| $161M | 0.03% |
2,194,480
+885,649
| +68% | +$63.6M |
|
355
Apollo Global Management
APO
$69B
| $159M | 0.03% |
1,195,591
-250,728
| -17% | -$35.5M |
|
356
Datadog
DDOG
$94B
| $159M | 0.03% |
1,117,654
+527,593
| +89% | +$72.6M |
|
357
ResMed
RMD
$31.1B
| $159M | 0.03% |
579,632
-159,315
| -22% | -$43.5M |
|
358
CALL
Advanced Micro Devices
AMD
$700B
| $158M | 0.03% |
978,200
-26,500
| -3% | -$4.28M |
|
359
PUT
Vistra
VST
$48.2B
| $158M | 0.03% |
807,400
+18,500
| +2% | +$3.67M |
|
360
Credo Technology Group
CRDO
$33.1B
| $158M | 0.03% |
1,082,081
+696,983
| +181% | +$85.3M |
|
361
Sempra
SRE
$58.1B
| $158M | 0.03% |
1,750,490
-4,657
| -0.3% | -$377K |
|
362
CALL
Akamai
AKAM
$15.6B
| $157M | 0.03% |
2,077,900
+251,100
| +14% | +$19.4M |
|
363
SLB Ltd
SLB
$72.7B
| $156M | 0.03% |
4,548,661
+437,294
| +11% | +$15.2M |
|
364
CALL
Invesco S&P 500 Equal Weight ETF
RSP
$97.3B
| $156M | 0.03% |
823,300
+483,600
| +142% | +$90.1M |
|
365
DuPont de Nemours
DD
$18.6B
| $156M | 0.03% |
1,594,828
-472,572
| -23% | -$44.5M |
|
366
PUT
CAVA Group
CAVA
$7.61B
| $155M | 0.03% |
2,572,000
+1,288,300
| +100% | +$97.6M |
|
367
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.3B
| $155M | 0.03% |
1,386,727
-732,723
| -35% | -$80.5M |
|
368
CALL
Thermo Fisher Scientific
TMO
$214B
| $153M | 0.03% |
+315,000
| New | +$147M |
|
369
Snowflake
SNOW
$98.1B
| $153M | 0.03% |
676,999
+65,821
| +11% | +$14.1M |
|
370
Sysco
SYY
$40.8B
| $153M | 0.03% |
1,854,262
+46,297
| +3% | +$3.7M |
|
371
Ametek
AME
$53.9B
| $152M | 0.03% |
807,020
+143,714
| +22% | +$26.4M |
|
|
CRWV
372
PUT
CoreWeave
CRWV
$33.2B
| $151M | 0.03% |
1,105,800
+1,084,800
| +5,166% | +$128M |
|
373
Idexx Laboratories
IDXX
$44.9B
| $151M | 0.03% |
236,670
-68,510
| -22% | -$41.6M |
|
374
Ulta Beauty
ULTA
$21.8B
| $151M | 0.03% |
276,463
+146,130
| +112% | +$74.9M |
|
375
CALL
JPMorgan Chase
JPM
$916B
| $151M | 0.03% |
479,100
+91,800
| +24% | +$27.3M |
|
Similar funds
Barclays's Q3 2025 Portfolio in Review
As of Q3 2025, Barclays held 5,800 positions worth $461B, up 5.7% from $436B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Barclays's Q3 2025 filing shows 615 new, 1,596 increased, 2,751 reduced and 340 closed positions. Its largest new stake was Paramount Skydance Corp: 13,646,704 shares worth $258M. The largest sale was NVIDIA, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Barclays's largest Q3 2025 buy was Paramount Skydance Corp: 13,646,704 shares worth $258M.
- Barclays added most to iShares iBoxx $ High Yield Corporate Bond ETF in Q3 2025, an estimated $712M increase.
- Barclays's biggest Q3 2025 reduction was NVIDIA, cutting an estimated $2.34B.
- Barclays fully exited Blueprint Medicines in Q3 2025, selling an estimated $200M.
- Barclays's ten largest holdings make up 40% of its $461B portfolio in Q3 2025.
- Barclays opened 615 new positions and closed 340 in Q3 2025.
- Barclays's portfolio value rose 5.7% quarter-over-quarter to $461B.
Based on Barclays's 13F filing for Q3 2025, filed 12 Nov 2025.